A patient receives an oral medication that undergoes significant first-pass metabolism. If hepatic enzyme activity is substantially induced, which consequence follows?

💡 Explanation

Increased hepatic enzyme activity enhances first-pass metabolism, breaking down more of the drug before it reaches systemic circulation; because of this, less drug is available. Therefore, bioavailability decreases, rather than increasing plasma concentration or effectiveness. Half-life isn't necessarily prolonged.

• What distinguishes the near-focus accommodation reflex in a 20-year-old from that in a 60-year-old regarding lens curvature?
• Why does chronic activation of hepatic stellate cells occur during persistent insulin resistance?
• If a patient with central diabetes insipidus receives a dose of a non-selective COX inhibitor like ibuprofen, which consequence becomes likely regarding urine osmolality in the collecting ducts?
• Which mechanism primarily explains why aggregated amyloid-beta proteins are cleared from the brain more slowly with increasing age, impacting cognitive function?
• Which outcome reduces urine volume due to elevated vasopressin?
• A woman experiences repeated early miscarriages. Which mechanism involving progesterone production likely contributes to this condition?